Kokuyo Camlin Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 25, 2025, 6:33 pm

Market Cap	1,061 Cr.
Current Price	105
High / Low	231/91.0
Stock P/E	89.4
Book Value	29.6
Dividend Yield	0.47 %
ROCE	17.0 %
ROE	14.5 %
Face Value	1.00
PEG Ratio	1.55

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Kokuyo Camlin Ltd

Competitors of Kokuyo Camlin Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
H T Media Ltd	455 Cr.	19.5	33.2/18.7		72.2	0.00 %	0.32 %	1.91 %	2.00
Gala Global Products Ltd	18.1 Cr.	3.32	4.43/2.80	34.2	8.05	0.00 %	1.23 %	0.33 %	5.00
DB Corp Ltd	3,935 Cr.	221	405/189	8.92	120	5.89 %	25.1 %	20.2 %	10.0
Vasa Retail and Overseas Ltd (VASA)	3.45 Cr.	5.75	8.55/4.10		29.7	0.00 %	5.30 %	%	10.0
Sandesh Ltd	886 Cr.	1,169	2,058/1,000	6.37	1,779	0.43 %	20.9 %	16.3 %	10.0
Industry Average	1,465.80 Cr	381.33		26.28	204.01	1.19%	10.11%	8.86%	6.15

All Competitor Stocks of Kokuyo Camlin Ltd

Quarterly Result

Metric	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Sales	100.79	132.07	70.59	131.27	142.67	163.95	196.15	189.85	172.69	216.25	235.79	194.84	168.03
Expenses	93.05	120.91	79.55	121.03	135.11	156.26	182.61	175.19	163.75	199.09	211.57	177.54	155.52
Operating Profit	7.74	11.16	-8.96	10.24	7.56	7.69	13.54	14.66	8.94	17.16	24.22	17.30	12.51
OPM %	7.68%	8.45%	-12.69%	7.80%	5.30%	4.69%	6.90%	7.72%	5.18%	7.94%	10.27%	8.88%	7.45%
Other Income	0.05	0.01	0.05	0.06	0.05	0.55	0.16	0.04	1.71	0.25	4.96	0.20	0.13
Interest	1.96	1.54	1.37	1.11	0.75	1.03	1.11	0.83	1.00	1.52	1.15	0.48	0.81
Depreciation	4.56	4.65	4.46	4.50	4.47	4.27	4.23	4.24	4.14	4.24	4.24	4.44	4.56
Profit before tax	1.27	4.98	-14.74	4.69	2.39	2.94	8.36	9.63	5.51	11.65	23.79	12.58	7.27
Tax %	0.00%	-1.00%	0.00%	0.00%	0.00%	0.00%	0.00%	60.33%	36.48%	24.81%	22.78%	24.64%	23.52%
Net Profit	1.26	5.03	-14.74	4.69	2.38	2.94	8.35	3.83	3.50	8.76	18.37	9.48	5.57
EPS in Rs	0.13	0.50	-1.47	0.47	0.24	0.29	0.83	0.38	0.35	0.87	1.83	0.95	0.56

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Metric	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Sales	384	436	468	544	614	630	630	689	634	403	508	775	815
Expenses	371	440	465	527	590	606	591	637	597	394	492	721	744
Operating Profit	13	-4	3	17	25	24	39	51	37	9	17	54	71
OPM %	3%	-1%	1%	3%	4%	4%	6%	7%	6%	2%	3%	7%	9%
Other Income	2	0	1	8	5	3	2	1	1	0	0	2	6
Interest	7	7	9	10	11	12	10	12	10	9	4	4	4
Depreciation	7	8	9	11	12	12	17	18	19	18	18	17	17
Profit before tax	2	-19	-13	4	7	2	15	23	9	-18	-5	35	55
Tax %	16%	28%	12%	-15%	28%	33%	34%	33%	50%	20%	0%	30%
Net Profit	1	-13	-12	5	5	2	10	15	4	-15	-5	24	42
EPS in Rs	0.13	-1.32	-1.15	0.49	0.52	0.15	0.98	1.52	0.43	-1.46	-0.47	2.44	4.21
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	21%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2012-2013	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023
YoY Net Profit Growth (%)	-1400.00%	7.69%	141.67%	0.00%	-60.00%	400.00%	50.00%	-73.33%	-475.00%	66.67%	580.00%
Change in YoY Net Profit Growth (%)	0.00%	1407.69%	133.97%	-141.67%	-60.00%	460.00%	-350.00%	-123.33%	-401.67%	541.67%	513.33%

Kokuyo Camlin Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:	6%
5 Years:	3%
3 Years:	26%
TTM:	-4%

Compounded Profit Growth
10 Years:	23%
5 Years:	22%
3 Years:	68%
TTM:	-72%

Stock Price CAGR
10 Years:	5%
5 Years:	8%
3 Years:	20%
1 Year:	-20%

Return on Equity
10 Years:	4%
5 Years:	4%
3 Years:	8%
Last Year:	14%

Last Updated: Unknown

Balance Sheet

Last Updated: November 14, 2024, 9:31 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	7	10	10	10	10	10	10	10	10	10	10	10	10
Reserves	112	199	203	208	218	228	239	239	234	229	253	286	287
Borrowings	65	71	73	99	138	138	173	126	78	70	56	80	39
Other Liabilities	91	113	132	130	114	108	132	106	68	79	124	116	91
Total Liabilities	274	393	418	447	481	485	555	481	390	389	442	493	427
Fixed Assets	70	79	107	105	102	159	165	178	165	149	140	161	159
CWIP	1	6	1	25	50	0	0	0	0	1	0	0	0
Investments	2	1	0	0	10	11	6	5	14	14	13	10	11
Other Assets	201	307	309	317	320	316	383	297	211	225	290	322	258
Total Assets	274	393	418	447	481	485	555	481	390	389	442	493	427

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-4	8	8	12	6	14	8	65	62	18	27	19
Cash from Investing Activity +	-17	-56	-54	10	-26	-12	-31	-7	-3	-6	-7	-18
Cash from Financing Activity +	17	99	-8	15	-8	-10	24	-57	-56	-12	-19	0
Net Cash Flow	-4	52	-54	37	-28	-8	1	-0	2	0	1	1

Free Cash Flow

Month	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Free Cash Flow	13.00	-69.00	-68.00	-56.00	-74.00	-114.00	-99.00	-122.00	-89.00	-69.00	-53.00	-2.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	56	55	52	54	62	63	62	43	46	43	35	37
Inventory Days	119	130	131	119	129	152	178	176	196	148	119	141
Days Payable	85	105	106	95	73	71	80	68	59	56	55	49
Cash Conversion Cycle	90	80	76	78	118	145	161	152	184	136	99	129
Working Capital Days	75	66	62	64	82	102	114	103	115	98	69	86
ROCE %	-6%	0%	5%	6%	4%	7%	9%	5%	-3%	-0%	12%	17%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%	74.99%
FIIs	0.06%	0.10%	0.12%	0.11%	0.18%	0.13%	0.18%	0.54%	0.57%	0.55%	0.52%	0.36%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.20%	0.04%	0.00%	0.00%
Public	24.95%	24.91%	24.89%	24.90%	24.82%	24.88%	24.83%	24.46%	24.24%	24.43%	24.49%	24.66%
No. of Shareholders	34,090	34,054	33,312	32,760	31,166	31,760	30,762	29,382	30,053	31,283	30,956	31,273

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
FaceValue	1.00	1.00	1.00	1.00	1.00
Basic EPS (Rs.)	1.52	0.98	0.15	0.52	0.50
Diluted EPS (Rs.)	1.52	0.98	0.15	0.52	0.50
Cash EPS (Rs.)	3.30	2.62	1.35	1.71	1.58
Book Value[Excl.RevalReserv]/Share (Rs.)	24.81	23.76	22.72	21.81	21.29
Book Value[Incl.RevalReserv]/Share (Rs.)	24.81	23.76	22.72	21.81	21.29
Revenue From Operations / Share (Rs.)	68.67	62.76	62.77	61.23	54.22
PBDIT / Share (Rs.)	5.20	4.09	2.60	2.98	2.49
PBIT / Share (Rs.)	3.41	2.44	1.40	1.80	1.40
PBT / Share (Rs.)	2.27	1.48	0.22	0.72	0.42
Net Profit / Share (Rs.)	1.52	0.97	0.14	0.52	0.49
NP After MI And SOA / Share (Rs.)	1.52	0.97	0.15	0.52	0.50
PBDIT Margin (%)	7.56	6.51	4.14	4.86	4.60
PBIT Margin (%)	4.97	3.89	2.22	2.93	2.58
PBT Margin (%)	3.30	2.36	0.35	1.19	0.78
Net Profit Margin (%)	2.20	1.55	0.23	0.85	0.90
NP After MI And SOA Margin (%)	2.20	1.55	0.24	0.85	0.92
Return on Networth / Equity (%)	6.10	4.11	0.66	2.39	2.35
Return on Capital Employeed (%)	12.00	9.63	5.66	6.95	5.94
Return On Assets (%)	2.74	2.02	0.31	1.16	1.20
Long Term Debt / Equity (X)	0.10	0.04	0.06	0.11	0.04
Total Debt / Equity (X)	0.67	0.55	0.56	0.43	0.32
Asset Turnover Ratio (%)	1.32	1.30	1.36	1.42	1.34
Current Ratio (X)	1.32	1.25	1.18	1.57	1.59
Quick Ratio (X)	0.57	0.56	0.57	0.90	0.90
Inventory Turnover Ratio (X)	1.47	1.58	1.88	1.91	1.97
Interest Coverage Ratio (X)	4.53	4.27	2.22	2.79	2.56
Interest Coverage Ratio (Post Tax) (X)	2.32	2.02	1.13	1.49	1.50
Enterprise Value (Cr.)	1125.92	1289.55	1011.53	855.59	732.38
EV / Net Operating Revenue (X)	1.63	2.05	1.61	1.39	1.35
EV / EBITDA (X)	21.61	31.45	38.79	28.61	29.27
MarketCap / Net Operating Revenue (X)	1.41	1.84	1.43	1.35	1.36
Price / BV (X)	3.89	4.87	3.94	3.79	3.46
Price / Net Operating Revenue (X)	1.41	1.84	1.43	1.35	1.36
EarningsYield	0.01	0.01	0.00	0.01	0.01

After reviewing the key financial ratios for Kokuyo Camlin Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 19, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 18) which recorded 1.00.
For Basic EPS (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 5. It has increased from 0.98 (Mar 18) to 1.52, marking an increase of 0.54.
For Diluted EPS (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 5. It has increased from 0.98 (Mar 18) to 1.52, marking an increase of 0.54.
For Cash EPS (Rs.), as of Mar 19, the value is 3.30. This value is within the healthy range. It has increased from 2.62 (Mar 18) to 3.30, marking an increase of 0.68.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 24.81. It has increased from 23.76 (Mar 18) to 24.81, marking an increase of 1.05.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 19, the value is 24.81. It has increased from 23.76 (Mar 18) to 24.81, marking an increase of 1.05.
For Revenue From Operations / Share (Rs.), as of Mar 19, the value is 68.67. It has increased from 62.76 (Mar 18) to 68.67, marking an increase of 5.91.
For PBDIT / Share (Rs.), as of Mar 19, the value is 5.20. This value is within the healthy range. It has increased from 4.09 (Mar 18) to 5.20, marking an increase of 1.11.
For PBIT / Share (Rs.), as of Mar 19, the value is 3.41. This value is within the healthy range. It has increased from 2.44 (Mar 18) to 3.41, marking an increase of 0.97.
For PBT / Share (Rs.), as of Mar 19, the value is 2.27. This value is within the healthy range. It has increased from 1.48 (Mar 18) to 2.27, marking an increase of 0.79.
For Net Profit / Share (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 2. It has increased from 0.97 (Mar 18) to 1.52, marking an increase of 0.55.
For NP After MI And SOA / Share (Rs.), as of Mar 19, the value is 1.52. This value is below the healthy minimum of 2. It has increased from 0.97 (Mar 18) to 1.52, marking an increase of 0.55.
For PBDIT Margin (%), as of Mar 19, the value is 7.56. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 18) to 7.56, marking an increase of 1.05.
For PBIT Margin (%), as of Mar 19, the value is 4.97. This value is below the healthy minimum of 10. It has increased from 3.89 (Mar 18) to 4.97, marking an increase of 1.08.
For PBT Margin (%), as of Mar 19, the value is 3.30. This value is below the healthy minimum of 10. It has increased from 2.36 (Mar 18) to 3.30, marking an increase of 0.94.
For Net Profit Margin (%), as of Mar 19, the value is 2.20. This value is below the healthy minimum of 5. It has increased from 1.55 (Mar 18) to 2.20, marking an increase of 0.65.
For NP After MI And SOA Margin (%), as of Mar 19, the value is 2.20. This value is below the healthy minimum of 8. It has increased from 1.55 (Mar 18) to 2.20, marking an increase of 0.65.
For Return on Networth / Equity (%), as of Mar 19, the value is 6.10. This value is below the healthy minimum of 15. It has increased from 4.11 (Mar 18) to 6.10, marking an increase of 1.99.
For Return on Capital Employeed (%), as of Mar 19, the value is 12.00. This value is within the healthy range. It has increased from 9.63 (Mar 18) to 12.00, marking an increase of 2.37.
For Return On Assets (%), as of Mar 19, the value is 2.74. This value is below the healthy minimum of 5. It has increased from 2.02 (Mar 18) to 2.74, marking an increase of 0.72.
For Long Term Debt / Equity (X), as of Mar 19, the value is 0.10. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 18) to 0.10, marking an increase of 0.06.
For Total Debt / Equity (X), as of Mar 19, the value is 0.67. This value is within the healthy range. It has increased from 0.55 (Mar 18) to 0.67, marking an increase of 0.12.
For Asset Turnover Ratio (%), as of Mar 19, the value is 1.32. It has increased from 1.30 (Mar 18) to 1.32, marking an increase of 0.02.
For Current Ratio (X), as of Mar 19, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.25 (Mar 18) to 1.32, marking an increase of 0.07.
For Quick Ratio (X), as of Mar 19, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 18) to 0.57, marking an increase of 0.01.
For Inventory Turnover Ratio (X), as of Mar 19, the value is 1.47. This value is below the healthy minimum of 4. It has decreased from 1.58 (Mar 18) to 1.47, marking a decrease of 0.11.
For Interest Coverage Ratio (X), as of Mar 19, the value is 4.53. This value is within the healthy range. It has increased from 4.27 (Mar 18) to 4.53, marking an increase of 0.26.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 19, the value is 2.32. This value is below the healthy minimum of 3. It has increased from 2.02 (Mar 18) to 2.32, marking an increase of 0.30.
For Enterprise Value (Cr.), as of Mar 19, the value is 1,125.92. It has decreased from 1,289.55 (Mar 18) to 1,125.92, marking a decrease of 163.63.
For EV / Net Operating Revenue (X), as of Mar 19, the value is 1.63. This value is within the healthy range. It has decreased from 2.05 (Mar 18) to 1.63, marking a decrease of 0.42.
For EV / EBITDA (X), as of Mar 19, the value is 21.61. This value exceeds the healthy maximum of 15. It has decreased from 31.45 (Mar 18) to 21.61, marking a decrease of 9.84.
For MarketCap / Net Operating Revenue (X), as of Mar 19, the value is 1.41. This value is within the healthy range. It has decreased from 1.84 (Mar 18) to 1.41, marking a decrease of 0.43.
For Price / BV (X), as of Mar 19, the value is 3.89. This value exceeds the healthy maximum of 3. It has decreased from 4.87 (Mar 18) to 3.89, marking a decrease of 0.98.
For Price / Net Operating Revenue (X), as of Mar 19, the value is 1.41. This value is within the healthy range. It has decreased from 1.84 (Mar 18) to 1.41, marking a decrease of 0.43.
For EarningsYield, as of Mar 19, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 18) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Kokuyo Camlin Ltd as of February 25, 2025 is: ₹308.41

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 25, 2025, Kokuyo Camlin Ltd is Undervalued by 193.72% compared to the current share price 105.00

Intrinsic Value of Kokuyo Camlin Ltd as of February 25, 2025 is: 486.73

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 25, 2025, Kokuyo Camlin Ltd is Undervalued by 363.55% compared to the current share price ₹105.00

Last 5 Year EPS CAGR: 57.82%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (225.77 cr) compared to borrowings (92.77 cr), indicating strong financial stability. The company has shown consistent growth in sales (579.23 cr) and profit (7.46 cr) over the years.	The stock has a low average ROCE of 4.67%, which may not be favorable. The stock has a high average Working Capital Days of 86.33, which may not be favorable. The stock has a high average Cash Conversion Cycle of 120.67, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kokuyo Camlin Ltd:
1. Net Profit Margin: 2.2%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 12% (Industry Average ROCE: 9.61%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 6.1% (Industry Average ROE: 7.97%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.32
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.57
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 89.4 (Industry average Stock P/E: 17.08)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.67
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Kokuyo Camlin Ltd. is a Public Limited Listed company incorporated on 24/12/1946 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24223MH1946PLC005434 and registration number is 005434. Currently Company is involved in the business activities of Manufacture of stationary articles such as pens and pencils of all kinds whether or not mechanical, pencil leads, date, sealing or numbering stamps, hand-operated devices for printing or embossing labels, hand printing sets, prepared typewriter ribbons and inked pads, globes etc.. Company's Total Operating Revenue is Rs. 815.89 Cr. and Equity Capital is Rs. 10.03 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Printing/Publishing/Stationery	Hilton House, 48/2, Central Road, Mumbai Maharashtra 400093	investorrelations@kokuyocamlin.com http://www.kokuyocamlin.com

Management
Name	Position Held
Mr. Subhash Dandekar	Chairman Emeritus
Mr. Dilip Dandekar	Chairman & Non-Exe.Director
Mr. Masaharu Inoue	Senior Vice Chairman
Mr. Shriram Dandekar	Vice Chairman & Exe.Director
Mr. Satish Veerappa	Managing Director
Mr. Takeo lguchi	Executive Director
Ms. Nandini Chopra	Independent Director
Ms. Naho Shigeta	Independent Director
Mr. Nilesh Modi	Independent Director
Mr. Naganath Subramanian Iyer	Independent Director
Mr. Tomoya Okada	Independent Director

FAQ

What is the latest intrinsic value of Kokuyo Camlin Ltd?

Let's break down Kokuyo Camlin Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 25 February 2025:

Calculated Fair Value: ₹308.41
Current Market Price: ₹105.00
Variance: 193.72% higher

This suggests Kokuyo Camlin Ltd is currently undervalued by 193.72%. For context:

Market Cap: 1,061 Cr.
52-Week Range: 231/91.0
Reserves (Sep 2024): 287 Cr
Liabilities: 427 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of Kokuyo Camlin Ltd?

The Market Cap of Kokuyo Camlin Ltd is 1,061 Cr..

What is the current Stock Price of Kokuyo Camlin Ltd as on 25 February 2025?

The current stock price of Kokuyo Camlin Ltd as on 25 February 2025 is ₹105.

What is the High / Low of Kokuyo Camlin Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Kokuyo Camlin Ltd stocks is 231/91.0.

What is the Stock P/E of Kokuyo Camlin Ltd?

The Stock P/E of Kokuyo Camlin Ltd is 89.4.

What is the Book Value of Kokuyo Camlin Ltd?

The Book Value of Kokuyo Camlin Ltd is 29.6.

What is the Dividend Yield of Kokuyo Camlin Ltd?

The Dividend Yield of Kokuyo Camlin Ltd is 0.47 %.

What is the ROCE of Kokuyo Camlin Ltd?

The ROCE of Kokuyo Camlin Ltd is 17.0 %.

What is the ROE of Kokuyo Camlin Ltd?

The ROE of Kokuyo Camlin Ltd is 14.5 %.

What is the Face Value of Kokuyo Camlin Ltd?

The Face Value of Kokuyo Camlin Ltd is 1.00.